Canopy Growth (CGC) Stock Forecast, Price & News

Canopy Growth (NASDAQ:CGC) Frequently Asked Questions

Is Canopy Growth a buy right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 6 sell ratings, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Canopy Growth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGC, but not buy additional shares or sell existing shares.
View analyst ratings for Canopy Growth or view top-rated stocks.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Friday, May 27th 2022.
View our earnings forecast for Canopy Growth.

How can I listen to Canopy Growth's earnings call?

Canopy Growth will be holding an earnings conference call on Friday, May 27th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Canopy Growth's earnings last quarter?

Canopy Growth Co. (NASDAQ:CGC) posted its quarterly earnings results on Friday, November, 5th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.14. The business had revenue of $145.70 million for the quarter, compared to analysts' expectations of $145.63 million. Canopy Growth had a negative net margin of 71.43% and a negative trailing twelve-month return on equity of 15.71%. The firm's revenue for the quarter was down 3.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.16 EPS.
View Canopy Growth's earnings history.

What price target have analysts set for CGC?

12 brokerages have issued 12 month price objectives for Canopy Growth's shares. Their forecasts range from $7.00 to $55.00. On average, they expect Canopy Growth's share price to reach $16.41 in the next twelve months. This suggests a possible upside of 178.6% from the stock's current price.
View analysts' price targets for Canopy Growth or view top-rated stocks among Wall Street analysts.

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:

• Mr. David Eric Klein, CEO & Director (Age 58, Pay $2.79M)
• Mr. Julious C. Grant Jr., Chief Commercial Officer (Age 54, Pay $686.07k)
• Ms. Judy Eunjoo Hong, VP of Investor Relations & Competitive Intelligence, Chief of Staff to the CEO and CFO (Age 49)
• Mr. Jonathan Di Tosto, Chief Operations Officer
• Mr. Thomas Carlton Stewart, VP & Chief Accounting Officer (Age 40)
• Mr. Thomas Shipley IV, Sr. VP of Quality Assurance & Chief Science Officer (Age 33)
• Ms. Holly Lukavsky, Chief HR Officer
• Mr. Timothy Rob Saunders F.C.A., FCPA, Strategic Advisor (Age 61)
• Jason Green, Head of Agriculture - Hemp Division
• Dr. Mark A. Ware, Chief Medical Officer

Who are some of Canopy Growth's key competitors?

Some companies that are related to Canopy Growth include STADA Arzneimittel Aktiengesellschaft (STDAF), Tilray (TLRY), USANA Health Sciences (USNA), Cronos Group (CRON), Cresco Labs (CRLBF), Sundial Growers (SNDL), Aurora Cannabis (ACB), Ascend Wellness (AAWH), Canopy Rivers (RIV), True Drinks (TRUU), Haymaker Acquisition Corp. III (HYAC), Mind Medicine (MindMed) (MNMD), Exactus (EXDI), Ayr Wellness (AYRWF) and MariMed (MRMD).
View all of CGC's competitors.

What is Canopy Growth's stock symbol?

Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.00%), Contrarius Investment Management Ltd (0.53%), Goldman Sachs Group Inc. (0.00%), Swiss National Bank (0.27%), Mirae Asset Global Investments Co. Ltd. (0.22%) and JPMorgan Chase & Co. (0.21%). Company insiders that own Canopy Growth stock include Phillip Stephen Shaer, Rade Nikola Kovacevic and Tomas Iv Shipley.
View institutional ownership trends for Canopy Growth.

Which major investors are selling Canopy Growth stock?

CGC stock was sold by a variety of institutional investors in the last quarter, including Bank of Nova Scotia, Cibc World Market Inc., Goldman Sachs Group Inc., Walleye Trading LLC, Ergoteles LLC, SIG North Trading ULC, Wolverine Asset Management LLC, and Alpine Woods Capital Investors LLC.
View insider buying and selling activity for Canopy Growth or view top insider-selling stocks.

Which major investors are buying Canopy Growth stock?

CGC stock was purchased by a variety of institutional investors in the last quarter, including Contrarius Investment Management Ltd, Prentice Capital Management LP, Bank of Montreal Can, Vanguard Group Inc., Sculptor Capital LP, GMT Capital Corp, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, and Connor Clark & Lunn Investment Management Ltd..
View insider buying and selling activity for Canopy Growth or or view top insider-buying stocks.

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $5.89.

How much money does Canopy Growth make?

Canopy Growth has a market capitalization of $2.32 billion and generates $414.03 million in revenue each year. The company earns $-1.32 billion in net income (profit) each year or ($1.02) on an earnings per share basis.

How many employees does Canopy Growth have?

Canopy Growth employs 3,259 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company can be reached via phone at (855) 558-9333 or via email at [email protected].